Skip Navigation


Rheumatology Advance Access originally published online on September 16, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
43/2/241    most recent
keh025v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brodmann, M.
Right arrow Articles by Pilger, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodmann, M.
Right arrow Articles by Pilger, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2004; 43: 241-242
© British Society for Rheumatology 2003; all rights reserved


Clinical

The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries

M. Brodmann, R. W. Lipp1, A. Passath1, G. Seinost, E. Pabst and E. Pilger

Divisions of Angiology and 1Nuclear Medicine and Endocrinology, Department of Internal Medicine, University Hospital, Graz, Austria.

Correspondence to: M. Brodmann, Division of Angiology, Department of Internal Medicine, Karl-Franzens University Hospital, A-8036 Graz, Austria. E-mail: marianne.brodmann{at}kfunigraz.ac.at

Objective. As one of the diagnostic criteria for giant cell arteritis affecting the temporal arteries (temporal arteritis) is still biopsy-proven vasculitis of the affected artery, the aim of our study was to evaluate the value of a non-invasive procedure, 2-18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (F-18-FDG-PET), in the diagnosis of Horton's disease.

Methods. During a period of 10 months, 22 consecutive patients with the clinical diagnosis of giant cell arteritis and a positive hypoechogenic halo in duplex sonography were re-examined with F-18-FDG-PET. Six patients had giant cell arteritis involving both the large arteries and the temporal arteries; five patients showed giant cell arteritis only in the large arteries without concomitant involvement of the temporal arteries, and the remaining 11 patients showed only involvement of the temporal arteries. All patients were examined by sonography and F-18-FDG-PET, which was performed before treatment with corticosteroids.

Results. All patients with positive signs of giant cell arteritis in duplex sonography, i.e. a hypoechogenic halo in the large arteries (thoracic, subclavian, axillary, iliac, aorta), also showed elevated FDG uptake in the same vessels, with complete agreement in the anatomical distribution of changes. When positive sonography was limited to the temporal arteries, FDG-PET was completely negative in the temporal arteries and all other arterial locations.

Conclusion. PET is not yet suitable for the diagnosis of temporal arteritis and therefore cannot replace invasive biopsy. F-18-FDG-PET is well suited to the demonstration of giant cell arteritis in arteries exceeding 4 mm in diameter.

KEY WORDS: F-18-FDG-PET, Giant cell arteritis, Duplex sonography, Temporal arteries, Horton's disease.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
W. A. Schmidt, A. Moll, A. Seifert, B. Schicke, E. Gromnica-Ihle, and A. Krause
Prognosis of large-vessel giant cell arteritis
Rheumatology, September 1, 2008; 47(9): 1406 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
F. Tato and U. Hoffmann
Giant cell arteritis: a systemic vascular disease
Vascular Medicine, May 1, 2008; 13(2): 127 - 140.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
N. Pipitone, A. Versari, and C. Salvarani
Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update
Rheumatology, April 1, 2008; 47(4): 403 - 408.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
W. A. Schmidt, A. Seifert, E. Gromnica-Ihle, A. Krause, and A. Natusch
Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis
Rheumatology, January 1, 2008; 47(1): 96 - 101.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. H. Shmerling
An 81-year-old woman with temporal arteritis.
JAMA, June 7, 2006; 295(21): 2525 - 2534.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
T. Belhocine
The right place of 18FDG PET for the diagnosis of giant cell arteritis--a response to the article of Brodmann et al.
Rheumatology, May 1, 2004; 43(5): 675 - 676.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.